Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 12 Apr 2023 for Adaptive Biotechnologies Corp, €6,389. Read the official filing
Filing timeline
BuySaleR. Mark Adams
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
R. Mark Adams: trading record in brief
R. Mark Adams is a declared insider of Adaptive Biotechnologies Corp (senior executive), with filings sourced from SEC (Form 4). In total, 13 filings cover trades dated from 14 June 2021 to 10 April 2023.
On the market, this insider has only sold: 10 sales, €428k in total. Other entries cover 2 share grants and 1 option exercise. 2023 to date brings no purchases and 2 sales.
Most recently, on 12 April 2023, the filings show an open-market sale worth €6,389 in Adaptive Biotechnologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to R. Mark Adams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
817 shares@ US$8.500.4% of flowCommon StockSEC:0001062993-23-009085:0
88,652 shares0Common StockSEC:0001062993-23-006327:0
995 shares@ US$8.500.5% of flowCommon StockSEC:0001209191-23-003052:0
841 shares@ US$7.610.4% of flowCommon StockSEC:0001209191-22-053372:0
2,284 shares@ US$7.131.1% of flowCommon StockSEC:0001209191-22-053372:1
825 shares@ US$9.530.5% of flowCommon StockSEC:0001209191-22-041730:0
831 shares@ US$13.171.3% of flowCommon StockSEC:0001209191-22-023916:0
74,135 shares0Common StockSEC:0001209191-22-017392:0
1,021 shares@ US$23.322.7% of flowCommon StockSEC:0001209191-22-002766:0
1,324 shares@ US$32.474.8% of flowCommon StockSEC:0001209191-21-060116:0
871 shares@ US$39.423.8% of flowCommon StockSEC:0001209191-21-046083:0
14,583 shares@ US$28.1044.6% of flowCommon StockSEC:0001209191-21-042290:0
8,914 shares@ US$38.7736.9% of flowCommon StockSEC:0001209191-21-041088:0
13 of 13 declarations
